The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions impr
The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.
대표청구항▼
We claim: 1. A method for providing nutritional supplements, the method comprising: administering to a pregnant or lactating woman about 10 mg to 100 mg of a first fatty acid compound selected from the group consisting of a linoleic acid compound, a linolenic acid compound, linolenic acid salts, li
We claim: 1. A method for providing nutritional supplements, the method comprising: administering to a pregnant or lactating woman about 10 mg to 100 mg of a first fatty acid compound selected from the group consisting of a linoleic acid compound, a linolenic acid compound, linolenic acid salts, linoleic acid salts, linolenic acid esters, linoleic acid esters, linolenic acid glyceride esters, linoleic acid glyceride esters, gamma-linolenic acid, dihomo-gamma-linolenic acid, dihomo-gamma-linolenic acid esters, dihomo-gamma-linolenic acid endoperoxides, docosapentanoic acid, eicosapentaenoic acid, docosahexaenoic acid and a combination thereof; about 10 mg to 1000 mg of a second fatty acid compound selected from the group consisting of a docosahexaenoic acid compound, an omega-3 fatty acid, an omega-2 fatty acid, eicosapentaenoic acid, docosapentanoic acid and a combination thereof; about 10 mg to 125 mg of a vitamin B.sub.6 compound; about 0.1 mg to 3 mg of a folic acid compound; about 100 mg to 2,000 mg of a calcium compound; about 25 mg to 500 mg of a vitamin C compound; and about 10 mg to 400 mg of a vitamin E compound, wherein the weight ratio of said first fatty acid compound to said second fatty acid compound is about 1:0.1 to 10. 2. The method of claim 1 wherein the supplements are in an oral dosage form. 3. The method of claim 2 wherein the oral dosage form is selected from the group consisting of immediate release, extended release, pulsed release, delayed release, controlled release and combinations thereof. 4. The method of claim 2, wherein said oral dosage form is selected from the group consisting of a chewable tablet, quick dissolve tablet, an effervescent tablet, a hard gelatin capsule, a soft gelatin capsule, reconstitutable particles, microparticles, a suspension, an elixir, a caplet and combinations thereof. 5. The method of claim 1 wherein the nutritional supplements further comprising administering a vitamin compound selected from the group consisting of a Vitamin A compound, a B complex vitamin compound, a Vitamin D compound and combinations thereof. 6. The method of 1 further comprising administering iron. 7. The method of claim 1, wherein the administration occurs once during a twenty-four hour period. 8. The method of claim 1, wherein the administration occurs at least twice during a twenty-four hour period.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (16)
Lien Eric L. (Malvern PA) Tomarelli Rudolph M. (Phoenixville PA), Corandomized fat compositions for infant formulas.
Chalupa William (Malvern PA) Kronfeld David S. (Coatesville PA) Schneider Paul L. (Milwaukee WI) Sklan David (Rehovot ILX), Methods of increasing milk yields in ruminants.
Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, Compositions and methods for lowering levels of high-sensitivity C-reactive protein (HS-CRP) in a subject.
Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh; Manku, Mehar, Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy.
Maines, Timothy J.; Machielse, Bernardus N M; Mehta, Bharat M.; Wisler, Gerald L.; Davidson, Michael H.; Wood, Peter Ralph, DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form.
Maines, Timothy J.; Machielse, Bernardus N M; Mehta, Bharat M.; Wisler, Gerald L.; Davidson, Michael H.; Wood, Peter Ralph, DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form.
Maines, Timothy J.; Machielse, Bernardus N.; Mehta, Bharat M.; Wisler, Gerald L.; Davidson, Michael H.; Wood, Peter Ralph, DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form.
Van Elswyk, Mary, Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.